When looking to alleviate persistent tinnitus, one quickly comes across Audistim, a dietary supplement sold in pharmacies and parapharmacies. The promise is appealing: a formula based on plants and melatonin to regain daily auditory comfort. The problem is that the boundary between nutritional support and therapeutic promise remains blurred, and the risks associated with this type of product are rarely detailed on sales sheets.
Audistim and regulatory status: what the dietary supplement framework says (and doesn’t say)
Audistim is not a medication. It is a dietary supplement, subject to food regulations and not those of medications. In practical terms, this means that no clinical trials are required before it is marketed. The manufacturer must ensure the safety of the ingredients used, but does not have to prove the product’s effectiveness on tinnitus or any other auditory disorder.
Its composition includes extracts of Ginkgo biloba, melatonin, zinc, and magnesium. Each of these active ingredients has documented properties in the scientific literature, but not specifically regarding the reduction of tinnitus. Recent recommendations from the Haute Autorité de Santé (HAS) confirm this: no dietary supplement targeting tinnitus has demonstrated effectiveness in robust clinical trials.
We can analyze in detail the health risks of Audistim to better understand this gap between commercial promise and available clinical data.
Ginkgo biloba and zinc in Audistim: active ingredients with documented limits
Ginkgo biloba is the ingredient most prominently featured in the communication surrounding Audistim. Its vasodilatory properties are well-known, and it is found in several medications aimed at improving blood circulation. The reasoning behind its inclusion is logical: better irrigation of the inner ear could reduce tinnitus symptoms.
Recent scientific syntheses show that the results of Ginkgo biloba on tinnitus remain contradictory. Some studies observe a slight subjective improvement, while others find no difference compared to a placebo. The dosage used in Audistim and the form of extract chosen are not always comparable to those in published studies, making extrapolation risky.
Zinc, another component, plays a recognized role in the functioning of the immune system and in certain metabolic processes of the inner ear. A zinc deficiency has been associated with auditory disorders in some patients. However, supplementing zinc in a person who is not deficient has not shown measurable benefits on hearing.
Melatonin: an indirect role on comfort, not on hearing
The melatonin present in the “Night” version of Audistim targets sleep, not tinnitus itself. Its inclusion is based on a valid observation: tinnitus often disrupts falling asleep. Improving sleep quality indirectly reduces perceived discomfort.
This remains a comfort effect, not a treatment for the auditory disorder. Melatonin does not act on the cause or intensity of tinnitus. Feedback varies on this point, with some users reporting a general sense of well-being while others notice no change.
Side effects of Audistim: signals not to be ignored
The product sheets mention “rare and minor” side effects, primarily mild digestive disturbances and drowsiness. This reassuring wording deserves to be nuanced.
- Ginkgo biloba has anticoagulant properties. When combined with blood-thinning treatments (aspirin, oral anticoagulants), it can increase the risk of bleeding. This drug interaction is not always clearly indicated on the packaging.
- Melatonin, even at low doses, can cause daytime drowsiness, headaches, or dizziness. In people taking antidepressants or benzodiazepines, it can alter the effect of these treatments.
- High doses of magnesium can sometimes lead to diarrhea or abdominal cramps, especially in individuals with sensitive digestion.
- Prolonged supplementation of zinc without proven deficiency can disrupt copper absorption, a trace element whose deficiency causes its own neurological symptoms.
Any regular intake of Audistim should be reported to one’s healthcare provider, especially if other treatments are ongoing. A “natural” dietary supplement is not synonymous with harmless.
Tinnitus and management recommended by HAS: where does Audistim stand
The updated recommendations from HAS position cognitive-behavioral therapies (CBT) as the first-line approach for disabling tinnitus. Hearing aids, when associated with hearing loss, constitute the other pillar of management. Noise generators and sound therapy complement the approach.
In this framework, Audistim is not included in any official recommendations for the management of tinnitus. This does not mean it is dangerous in itself, but that it exists in a zone where the commercial promise exceeds what science currently validates.
The main risk is not so much the direct side effect but the delay in management. Someone relying solely on a dietary supplement to manage chronic tinnitus may postpone an ENT consultation or an audiometric assessment, losing precious time for solutions whose effectiveness is documented.
When to consult rather than supplement
Sudden onset tinnitus, unilateral tinnitus, or tinnitus accompanied by dizziness or sudden hearing loss require prompt medical consultation. In these cases, a dietary supplement never replaces a medical diagnosis.
Audistim may find its place as a complementary support, in conjunction with audiological follow-up, for individuals whose tinnitus is stable and moderate. But this place remains that of an adjunct, not a treatment. Keeping this distinction in mind is what separates an informed health approach from a purchase driven by marketing.
